Menu
Back to Journals » Core Evidence » Volume 3 » Issue 1
ESCI
SJR OA
Core Evidence
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 3, 2008
Review
Ivabradine: the evidence of its therapeutic impact in angina
Guillaume Marquis-Gravel, Jean-Claude Tardif
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Omalizumab: the evidence for its place in the treatment of allergic asthma
Diarmuid M. McNicholl, Liam G. Heaney
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Prucalopride: the evidence for its use in the treatment of chronic constipation
Georges Coremans
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome
Arash Aghel, W. H. Wilson Tang
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
Louise Profit, Paul Chrisp, Carole Nadin
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008